AGRXUnknownLarge-Cap
AGILE THERAPEUTICS INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for AGILE THERAPEUTICS INC (AGRX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are AGRX insiders buying or selling?
AGILE THERAPEUTICS INC insiders reported 20 open-market buys ($26.0M) and 3 sells ($184.8K) across 23 Form 4 filings — a net buying position of $25.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Oct 15, 2021)
Total Form 4 filings
23
SEC EDGAR
Insider filers
5
Insider buys (20)
$26.0M
Insider sells (3)
$184.8K
Insider sentiment
Net buyingNet insider flow of $25.8M in net buying.
Recent AGRX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 15, 2021 | Joseph Edelman | 10% Owner | Purchase | 5.7M | $0.85 | $4.9M |
| Oct 14, 2021 | Dennis Reilly | Chief Financial Officer | Purchase | 58.8K | $0.00 | $0 |
| Oct 14, 2021 | Alfred Altomari | Chief Executive Officer | Purchase | 58.8K | $0.00 | $0 |
| Jul 29, 2021 | Alfred Altomari | Chief Executive Officer | Purchase | 26.2K | $1.26 | $33.1K |
| Jul 29, 2021 | Dennis Reilly | Chief Financial Officer | Purchase | 50.0K | $1.08 | $54.1K |
| May 19, 2021 | Alfred Altomari | Chief Executive Officer | Purchase | 20.0K | $1.61 | $32.2K |
| May 12, 2021 | Dennis Reilly | Chief Financial Officer | Purchase | 20.0K | $1.35 | $27.0K |
| Mar 30, 2021 | Jason Butch | Principal Accounting Officer | Purchase | 10.0K | $2.01 | $20.1K |
| Mar 23, 2021 | Alfred Altomari | Chief Executive Officer | Purchase | 12.5K | $2.00 | $25.0K |
| Mar 23, 2021 | Dennis Reilly | Chief Financial Officer | Purchase | 50.0K | $2.05 | $102.5K |
| Sep 28, 2020 | Dennis Reilly | Chief Financial Officer | Purchase | 9.0K | $2.85 | $25.6K |
| Mar 17, 2020 | Joseph Edelman | 10% Owner | Purchase | 1.0M | $1.75 | $1.8M |
| Mar 6, 2020 | Dennis Reilly | Chief Financial Officer | Purchase | 75.0K | $2.33 | $174.8K |
| Feb 28, 2020 | Alfred Altomari | Chief Executive Officer | Purchase | 10.0K | $2.71 | $27.1K |
| Feb 26, 2020 | Joseph Edelman | 10% Owner | Purchase | 3.0M | $3.00 | $9.0M |
| Nov 19, 2019 | Joseph Edelman | 10% Owner | Purchase | 5.8M | $1.68 | $9.7M |
| Oct 31, 2019 | Joseph Edelman | 10% Owner | Sale | 760.3K | $0.44 | $334.5K |
| Oct 30, 2019 | Joseph Edelman | 10% Owner | Sale | 1.5M | — | -$239.2K |
| Jun 11, 2019 | Alfred Altomari | Chief Executive Officer | Purchase | 20.0K | $1.27 | $25.4K |
| Apr 1, 2019 | Alfred Altomari | Chief Executive Officer | Purchase | 25.0K | $1.54 | $38.5K |
| Apr 1, 2019 | Abhijeet J Lele | Director | Purchase | 20.0K | $1.54 | $30.8K |
| Mar 26, 2019 | Alfred Altomari | Chief Executive Officer | Purchase | 25.0K | $1.54 | $38.5K |
| Jul 26, 2018 | Joseph Edelman | Other | Sale | 298.6K | $0.30 | $89.4K |
Showing the 23 most recent of 23 Form 4 filings for AGILE THERAPEUTICS INC.
Most active AGRX insiders
- Alfred Altomari8 filings
- Joseph Edelman7 filings
- Dennis Reilly6 filings
- Abhijeet J Lele1 filing
- Jason Butch1 filing
Ask anything about AGRX insider activity
Use Trabud's AI agent to query AGILE THERAPEUTICS INC's Form 4 history in plain English — "Show me AGRX CEO purchases this year" or compare it against any other ticker.
Open the AI agentAGRX insider trading FAQ
Are AGILE THERAPEUTICS INC insiders buying or selling?
Across 23 SEC Form 4 filings, AGILE THERAPEUTICS INC (AGRX) insiders reported 20 open-market purchases totaling $26.0M and 3 sales totaling $184.8K. That is a net buying position of $25.8M.
How many insiders trade AGRX stock?
5 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AGILE THERAPEUTICS INC. The most recent filing was accepted on Oct 15, 2021.
Where does Trabud get AGRX insider trading data?
All AGRX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.